4.47 (s, 1H), 2.41 (ddd, J1 ) 12.8 Hz, J2 ) 3.8 Hz, J3 ) 2.6 Hz,
1H), 2.16 (br d, J ) 11.3 Hz, 1H), 2.13-1.92 (m, 2H), 1.86-1.48
(m, 5H), 1.45-1.15 (m, 8H), 1.10 (d, J ) 7.4 Hz, 9H), 1.07 (d, J
) 7.4 Hz, 9H), 0.88 (s, 3H), 0.81 (s, 3H), 0.69 (s, 3H); 13C NMR
(75 MHz, CDCl3) δ ) 152.8, 148.8, 146.8, 140.6, 107.9, 106.2,
64.2, 55.4, 52.2, 42.1, 39.4, 39.0, 38.3, 33.61, 33.58, 32.3, 24.5,
21.7, 19.4, 18.8 (3C), 18.7 (3C), 14.6, 11.7 (3C); HRMS (ESI+)
calcd for C29H50O2SiNa 481.3478 [M + Na+], found 481.3473.
In conclusion, a fast (six steps in total) and efficient (overall
yield 53%) synthesis of (+)-zerumin B and (+)-12-epi-zerumin
B has been accomplished. The key step of the synthesis involved
the regioselective transformation of a 3-substituted furan into
the R-substituted γ-hydroxybutenolide moiety13 of the natural
compound by the utilization of a [1,4] OfC silyl migration
1
followed by an oxidation with O2.
7a: 1H NMR (300 MHz, CDCl3) δ ) 7.63 (d, J ) 1.6 Hz, 1H),
6.49 (d, J ) 1.6 Hz, 1H), 4.88 (d, J ) 1.1 Hz, 1H), 4.79 (s, 1H),
4.74 (t, J ) 7.1 Hz, 1H), 2.34 (ddd, J1 ) 12.8 Hz, J2 ) 3.9 Hz, J3
) 2.4 Hz, 1H), 2.05-1.13 (m, 14H), 1.11 (d, J ) 7.4 Hz, 9H),
1.04 (d, J ) 7.4 Hz, 9H), 1.00-0.84 (m, 2H), 0.82 (s, 3H), 0.78
(s, 3H), 0.70 (s, 3H); 13C NMR (125 MHz, CDCl3) δ ) 154.5,
149.3, 147.0, 139.4, 107.6, 107.0, 65.7, 55.2, 52.6, 41.9, 39.6, 38.9,
38.0, 33.5(2C), 31.8, 24.2, 21.7, 19.3, 18.9 (3C), 18.7 (3C), 14.4,
11.8 (3C); HRMS (ESI+) calcd for C29H50O2SiNa 481.3478 [M
+ Na+], found 481.3473.
Experimental Section
Diastereomeric (1-(Furan-3-yl)-2-((1S,8aS)-5,5,8a-trimethyl-
2-methylenedecahydronaphthalen-1-yl)ethoxy)triisopropylsi-
lane (6a,b). To a solution of furanol 5b (66 mg, 0.22 mmol, 1.0
equiv, less polar diastereoisomer) in dry DCM (3 mL) was added
2,6-lutidine (53 µL, 0.46 mmol, 2.1 equiv). The reaction mixture
was cooled to -5 °C, and TIPSOTf (92 µL, 0.34 mmol, 1.56 equiv)
was added dropwise. Stirring was continued for 15 min before the
reaction was quenched with NaHCO3 (2 mL). The reaction mixture
was diluted with Et2O (10 mL) and washed with H2O (5 mL). The
organic layer was dried (MgSO4), filtered, and concentrated under
reduced pressure. Purification by flash column chromatography
(silica gel, hexanes/EtOAc ) 50:1 v/v) afforded TIPS-protected
alcohol 6b (90 mg, 90%). Exactly the same experimental procedure
was applied in the case of furanol 5a (60 mg, 0.20 mmol, of the
more polar diastereoisomer) to give the TIPS-protected alcohol 6a
(83 mg, 91%).
(+)-Zerumin B (1) and (+)-epi-Zerumin B (9). A solution of
the furan 7b (82 mg, 0.18 mmol, 1.0 equiv) in DCM (8 mL)
containing methylene blue (10-4 M) was placed in a test tube, and
oxygen was bubbled gently through it. The solution was cooled to
0 °C and irradiated with a xenon 300 W lamp for 1 min after which
complete consumption of the starting material was observed (based
on TLC). SiO2 and a few drops of H2O were added, and the mixture
was stirred vigorously for 1 h. The solvent was removed in vacuo,
and the residue was purified by flash column chromatography (silica
gel, hexanes/EtOAc ) 2:1 f 1:2 v/v) to afford (+)-zerumin B (1,
50 mg, 83%, 1/1 ratio of diastereoisomers). Exactly the same
experimental procedure was applied to the case of furan 7a (75
mg, 0.16 mmol) to afford (+)-epi-zerumin B (45 mg, 82%, 1/1
ratio of diastereoisomers).
6b: 1H NMR (300 MHz, CDCl3) δ ) 7.34 (t, J ) 1.5 Hz, 1H),
7.30 (s, 1H), 6.43 (d, J ) 1.0 Hz, 1H), 4.86 (d, J ) 1.4 Hz, 1H),
4.80 (dd, J1 ) 10.0 Hz, J2 ) 1.5 Hz, 1H), 4.47 (s, 1H), 2.41 (ddd,
J1 ) 12.7 Hz, J2 ) 4.0 Hz, J3 ) 2.3 Hz, 1H), 2.14 (br d, J ) 11.0
Hz, 1H), 2.07-1.05 (m, 12H), 1.05-0.93 (m, 21H), 0.90 (s, 3H),
0.81 (s, 3H), 0.65 (s, 3H); 13C NMR (125 MHz, CDCl3) δ ) 149.2,
142.7, 138.0, 131.1, 108.9, 106.6, 65.7, 55.8, 52.3, 42.3, 39.3, 38.9,
38.2, 35.2, 33.7, 33.6, 24.4, 21.7, 19.4, 18.2 (3C), 18.0 (3C), 14.7,
12.6 (3C) ppm; HRMS (ESI+) calcd for C29H50O2SiNa 481.3478
[M + Na+], found 481.3473.
24
(+)-Zerumin B (1): [R]D24 +41.7 (c ) 4.0, acetone) [lit.4 [R]D
+42.8 (c ) 0.25, acetone)]; 1H NMR (300 MHz, CDCl3) δ ) 7.04
(s, 1H + 1H), 6.11 (s, 1H + 1H), 4.91 (br s, 1-OH + 1-OH), 4.88
(s, 1H + 1H), 4.67 (s, 1H + 1H), 4.53 (br d, J ) 9.9 Hz, 1H +
1H), 2.76 (br s, 1-OH + 1-OH), 2.41 (md, J ) 12.9 Hz, 1H +
1H), 2.09-0.95 (m, 13H + 13H), 0.88 (s, 3H + 3H), 0.80 (s, 3H
+ 3H), 0.67 (s, 3H + 3H); 13C NMR (75 MHz, CDCl3) δ ) 170.4
(2C), 148.2 (2C), 143.1 (2C), 141.4 (2C), 107.2 (2C), 97.1, 96.9,
65.5 (2C), 55.5 (2C), 51.8 (2C), 42.0 (2C), 39.3 (2C), 39.0 (2C),
38.2 (2C), 33.6 (4C), 29.7 (2C), 24.3 (2C), 21.7 (2C), 19.3 (2C),
14.6 (2C); HRMS (ESI+) calcd for C20H30O4Na 357.2042 [M +
Na+], found 357.2036.
6a: 1H NMR (300 MHz, CDCl3) δ ) 7.36 (t, J ) 1.5 Hz, 1H),
7.22 (s, 1H), 6.40 (d, J ) 1.1 Hz, 1H), 4.87 (s, 1H), 4.82 (dd, J1
) 10.5 Hz, J2 ) 4.3 Hz, 1H), 4.69 (s, 1H), 2.36 (ddd, J1 ) 12.7
Hz, J2 ) 4.1 Hz, J3 ) 2.4 Hz, 1H), 1.99-1.05 (m, 12H), 1.05-
0.96 (m, 21H), 0.92 (m, 1H), 0.82 (s, 3H), 0.78 (s, 3H), 0.70 (s,
3H); 13C NMR (125 MHz, CDCl3) δ ) 149.0, 142.8, 139.1, 129.5,
108.8, 106.2, 66.2, 55.4, 52.6, 42.0, 39.3, 38.6, 38.3, 33.8, 33.5,
33.46, 24.4, 21.7, 19.3, 18.1 (3C), 18.0 (3C), 14.8, 12.3 (3C); HRMS
(ESI+) calcd for C29H50O2SiNa 481.3478 [M + Na+], found
481.3473.
24
(+)-epi-Zerumin B (9): [R]D +5.9 (c ) 0.84, acetone) [lit.4
24
1
[R]D +5.5 (c ) 0.85, acetone)]; H NMR (300 MHz, CDCl3) δ
) 7.04 (s, 1H), 6.99 (s, 1H), 6.11 (br s, 1H + 1H), 5.44 (br s,
1-OH + 1-OH), 4.88 (br s, 1H + 1H), 4.68 (br s, 1H + 1H), 4.51
(br t, J ) 6.5 Hz, 1H + 1H), 3.30 (br s, 1-OH + 1-OH), 2.39 (br
d, J ) 12.5 Hz, 1H + 1H), 2.10-0.88 (m, 13H + 13H), 0.86 (s,
3H + 3H), 0.78 (s, 3H + 3H), 0.67 (s, 3H + 3H) ppm; 13C NMR
(75 MHz, CDCl3) δ ) 171.1, 170.7, 149.3, 149.1, 145.4, 144.8,
139.6, 138.5, 107.1, 106.9, 97.52, 97.37, 67.2, 66.5, 55.44 55.40,
53.3, 53.0, 42.0 (2C), 39.9, 39.8, 38.93, 38.89, 38.18, 38.13, 33.54
(2C), 33.47 (2C), 29.8, 29.4, 24.3 (2C), 21.7 (2C), 19.24, 19.22,
14.44, 14.39; HRMS (ESI+) calcd for C20H30O4Na 357.2042 [M
+ Na+], found 357.2036.
Diastereomeric 1-(2-(Triisopropylsilyl)furan-3-yl)-2-((1S,8aS)-
5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)etha-
nol (7a,b). To a stirred solution of TIPS-protected furanol 6b (90
mg, 0.20 mmol, 1.0 equiv) in dry THF (3 mL) at ambient
temperature was added dry HMPA (41 µL, 0.24 mmol, 1.2 equiv)
followed by dropwise addition of n-BuLi (1.6 M in Hex, 147 µL,
0.24 mmol, 1.2 equiv). After 15 min of stirring, the reaction mixture
was quenched with satd NH4Cl (1 mL), diluted with Et2O (10 mL),
and washed with H2O (5 mL). The organic layer was dried
(MgSO4), filtered, and concentrated under reduced pressure.
Purification with flash column chromatography (silica gel, hexanes/
EtOAc ) 50:1 v/v) afforded TIPS furanol 7b (82 mg, 91%). Exactly
the same experimental procedure was applied in the case of 6a (83
mg, 0.18 mmol) to afford 75 mg of 7a (90%).
Acknowledgment. We thank Dr. Tamsyn Montagnon for
helpful discussions. The project was cofunded by the European
Social Fund and National Resources (B EPEAEK, Pythagoras
program) and with a National Fellowship Institute (IKY)
fellowship (I.M.).
7b: 1H NMR (300 MHz, CDCl3) δ ) 7.61 (d, J ) 1.6 Hz, 1H),
6.51 (d, J ) 1.6 Hz, 1H), 4.82 (s, 1H), 4.72 (d, J ) 10.4 Hz, 1H),
(12) For a very recent example of base-assisted regio- and diastereose-
lective conversion of 3-substituted furans to 3-substituted 4-hydroxybuteno-
lides, see: Patil, S. N.; Liu, F. Org. Lett. 2007, 9, 195-198.
(13) After completion of this work, a very interesting fluoride-assisted
regioselective conversion of 3-substituted furans to R-substituted γ-hy-
droxybutenolides using singlet oxygen was reported: Patil, S. N.; Liu, F.
J. Org. Chem. 2007, 72, 6305-6308.
1
Supporting Information Available: Copies of H NMR and
13C NMR spectra for all new compounds. This material is available
JO7025405
J. Org. Chem, Vol. 73, No. 5, 2008 2023